CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2316883
下载链接
链接失效反馈官方服务：
资源简介：
The objective is to compare the efficacy and safety of CAPOXIRI+BEV therapy versus FOLFOXIRI+BEV therapy as first-line therapy in patients with metastatic colorectal cancer (mCRC).
创建时间：
2019-10-15
